Advance Care Planning: Promoting Effective & Aligned Communication in

Status Active, not recruiting

Clinical Trial Summary

In this research study, the investigators are working to help oncologists better serve patients by delivering more patient-centered, goal-concordant care that may improve health care delivery. - It is expected that about 30,000 people will take part in this research study, 29,550 of these patients, the vast majority, will be included only for medical record review.

Clinical Trial Description

The purpose of this study is to improve the quality of care provided to millions of older Americans with cancer. The investigators are working to help oncologists better serve patients by delivering more patient-centered, goal-concordant care that may dramatically improve health care delivery. This is pragmatic stepped wedge cluster randomized trial (SW-CRT) of a Comprehensive ACP (Advance Care Planning) Program among older oncology patients. The ACP Program will include training clinicians in communication skills and using video decision aids for participants. - This study will involve medical record review of 30,000 people age 65 or older with advanced cancer. We will also recruit 450 eligible patients (150 patients from each of our three sites broken down into 75 patients during the control phase and 75 patients during the intervention phase) to conduct a survey for our secondary patient-centered outcomes (confidence, satisfaction with physician communication, patient decisional satisfaction and regret). From among this sub-group we will engage 240 participants (80 from each of our three sites broken down into 40 patients during the control phase and 40 patients during the intervention phase) in an activity to film video declarations of their preferences. During the first year, three pilot sites (one at each health care system) will trial the intervention. The subjects recruited at these pilot sites will not be included in the final analysis. Thus, the main trial will begin during year 2 and continue through year 5 with recruitment of 30,000 subjects for the primary outcome at 30 oncology clinics. The first year pilot will serve to inform the larger roll-out and the intervention may change during the first year based on pilot-clinic experience. ;

Study Design

Related Conditions & MeSH terms

Other Cancer

Clinical Trial Details

NCT number	NCT03609177
Study type	Interventional
Source	Dana-Farber Cancer Institute
Contact
Status	Active, not recruiting
Phase	N/A
Start date	September 18, 2018
Completion date	September 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04340024` - Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
Active, not recruiting	`NCT04591431` - The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy	Phase 2
Recruiting	`NCT06103669` - Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)	N/A
Recruiting	`NCT04585750` - The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)	Phase 1/Phase 2
Recruiting	`NCT03160274` - Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Completed	`NCT03736746` - Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals	N/A
Completed	`NCT03638453` - Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention	N/A
Recruiting	`NCT06397651` - A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care	N/A
Active, not recruiting	`NCT03850912` - Symptom Management Implementation of Patient Reported Outcomes in Oncology	N/A
Completed	`NCT03392090` - SHARE (Sharing Goals and Preferences) Study	N/A
Completed	`NCT03244826` - Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation	N/A
Recruiting	`NCT03517332` - Circulating Tumor DNA Exposure in Peripheral Blood
Completed	`NCT03721926` - A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer	N/A
Active, not recruiting	`NCT03967379` - Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors	N/A
Completed	`NCT05176860` - Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy	N/A
Active, not recruiting	`NCT03674047` - Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)	Phase 2
Active, not recruiting	`NCT03752268` - Development of an Intervention to Enhance Cancer Pain Management	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly — ACP-PEACE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms